Answers are grounded in this paper and cite their sources.
Background: Hexavalent chromium (Cr(VI)) is a well-established environmental and occupational toxicant. Following cellular uptake and intracellular reduction, Cr(VI) can generate reactive intermediates that promote oxidative and genotoxic injury, mitochondrial dysfunction, and epigenetic alterations, providing mechanistic pathways potentially relevant to thyroid vulnerability. Aim: This narrative review examines evidence linking species-characterized Cr(VI), or total chromium where valence is unresolved, with thyroid functional, structural, and tissue-injury outcomes across human and experimental models. It also evaluates systemic and multi-omics biomarkers as candidates for future thyroid-focused validation. Methods: Evidence was critically synthesized across human Cr(VI) biomonitoring studies, experimental thyroid toxicology, chromium-related omics investigations, and translational thyroid biomarker research using an evidence-stratified framework that distinguishes direct evidence from mechanistic support and translational inference. Results: Human studies support Cr(VI)-associated oxidative DNA damage, altered mitochondrial indices, selected epigenetic changes, and systemic perturbations in lipid-, amino-acid-, nucleotide-, and steroid-related metabolic pathways. Human studies have related total chromium to thyroid hormones or tumor characteristics without resolving chromium valence. Experimental studies demonstrate thyroid hormonal imbalance, oxidative and inflammatory injury, DNA damage, and histopathological alterations. Broader thyroid multi-omics research identifies metabolomic, circulating nucleic acid, mitochondrial, non-coding RNA, and extracellular-vesicle markers with translational potential; however, these markers have not been validated as indicators of chromium-specific thyroid toxicity. Conclusions: Current evidence supports a biologically coherent but incomplete exposure-to-effect framework linking Cr(VI) with molecular processes relevant to thyroid vulnerability, without establishing a direct causal relationship with human thyroid dysfunction or thyroid cancer. Recommendations: Prospective human studies integrating chromium exposure assessment, thyroid function, and harmonized multi-omics profiling are required to validate mechanistically informed biomarker panels.
No takes yet. Share an insight, caveat, or question.
Georgaki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: